Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Garraud

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 2, 2019
Biography: Prof. Dr. Olivier Garraud MD PhDOlivier Garraud
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 14, 2011
[Acknowledged risks in transfusion and impact of taken measures on those risks]Olivier Garraud
Presse Medicale (Paris, France : 1983)|January 25, 2015
[Blood transfusion and paradoxes]Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 8, 2020
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 5, 2022
Anemia in the very aged person: How are treatment options discussed and when is red blood cell component transfusion proposed?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 28, 2017
Hemolysis in six week-old autologous red blood cell components questioned: Worth addressing the issue of homologous components as well?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 25, 2017
Clinical trials in Transfusion Medicine and hemotherapy: Worth moving forward in evaluating 'fresh' versus 'old' blood cell components?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 25, 2019
Therapeutic plasma exchange, 2019 and beyondOlivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 8, 2014
World Apheresis Association letter to the WHO: the World Apheresis Association urges the development of preparedness plans to make specific plasma available when urgently neededOlivier Garraud,
Frontiers in Immunology|June 20, 2015
Editorial: Platelets as Immune Cells in Physiology and ImmunopathologyOlivier Garraud
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 2, 2019
Biography: Prof. Dr. Olivier Garraud MD PhDOlivier Garraud
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 14, 2011
[Acknowledged risks in transfusion and impact of taken measures on those risks]Olivier Garraud
Presse Medicale (Paris, France : 1983)|January 25, 2015
[Blood transfusion and paradoxes]Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 8, 2020
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 5, 2022
Anemia in the very aged person: How are treatment options discussed and when is red blood cell component transfusion proposed?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 28, 2017
Hemolysis in six week-old autologous red blood cell components questioned: Worth addressing the issue of homologous components as well?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 25, 2017
Clinical trials in Transfusion Medicine and hemotherapy: Worth moving forward in evaluating 'fresh' versus 'old' blood cell components?Olivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 25, 2019
Therapeutic plasma exchange, 2019 and beyondOlivier Garraud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 8, 2014
World Apheresis Association letter to the WHO: the World Apheresis Association urges the development of preparedness plans to make specific plasma available when urgently neededOlivier Garraud,
Frontiers in Immunology|June 20, 2015
Editorial: Platelets as Immune Cells in Physiology and ImmunopathologyOlivier Garraud
Pageof 22